https://biotechmorning.com/news/lilly-blood-test-rivals-pet-scan-alzheimers Biotech Morning en 2026-07-18T14:27:34.111Z A $200 Blood Draw That Could Replace a $5,000 Brain Scan https://biotechmorning.com/news/roche-exits-huntingtons-gene-silencing Biotech Morning en 2026-07-18T14:26:44.243Z Roche Just Walked Away From Huntington's. Now What? https://biotechmorning.com/news/vertex-10-billion-crinetics-endocrinology-bet Biotech Morning en 2026-07-18T14:25:50.189Z Vertex Just Bet $10 Billion It Can Master a Fifth Disease https://biotechmorning.com/news/merck-kgaa-bio-techne-11-billion-acquisition Biotech Morning en 2026-07-18T14:24:55.649Z Merck KGaA Just Dropped $11.3 Billion on the Company You've Never Heard Of https://biotechmorning.com/news/hansoh-backdoor-wall-street-reverse-merger Biotech Morning en 2026-07-18T14:24:00.915Z Hansoh Found a Backdoor Into Wall Street https://biotechmorning.com/news/jasper-kira-merger-rescue-deal-flowchart Biotech Morning en 2026-07-18T14:23:03.977Z The Biotech Rescue Deal That Needed a Flowchart https://biotechmorning.com/news/wegovy-mash-liver-disease-india-approval Biotech Morning en 2026-07-18T14:22:02.034Z Wegovy Just Became a Liver Drug. https://biotechmorning.com/news/ractigen-rag17-als-nature-medicine Biotech Morning en 2026-07-18T14:21:04.897Z A Single Shot Silenced a Disease Gene for Months. ALS Research Just Got Weird. https://biotechmorning.com/news/astrazeneca-chia-tai-tianqing-copd-deal Biotech Morning en 2026-07-18T14:20:10.669Z AstraZeneca Just Paid $200 Million for a Chinese Lung Drug You've Never Heard Of https://biotechmorning.com/news/takeda-zasocitinib-phase-3-psoriasis-results Biotech Morning en 2026-07-17T14:28:51.617Z Takeda's $4 Billion Psoriasis Bet Just Dropped Receipts https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo-2 Biotech Morning en 2026-07-17T14:28:00.890Z The MyoKardia Crew Is Back, and Wall Street Just Handed Them $400 Million https://biotechmorning.com/news/italy-state-backed-angelini-catalyst-rare-disease-deal Biotech Morning en 2026-07-17T14:27:05.257Z Italy Just Bought Its Way Into U.S. Rare Disease https://biotechmorning.com/news/lilly-atabeckley-psychedelics-acquisition Biotech Morning en 2026-07-17T14:26:10.097Z Lilly Just Dropped $3.8 Billion on a Psychedelic Trip https://biotechmorning.com/news/merck-lipfendra-oral-pcsk9-cholesterol-pill Biotech Morning en 2026-07-17T14:25:19.363Z The Cholesterol Pill That Could Kill the Needle https://biotechmorning.com/news/fabhalta-traditional-approval-iga-nephropathy Biotech Morning en 2026-07-17T14:24:24.254Z The Kidney Drug That Just Graduated From Probation https://biotechmorning.com/news/tepezza-loses-ted-monopoly-viridian-lumvoa-approved Biotech Morning en 2026-07-17T14:22:53.986Z Tepezza Just Lost the Throne It's Held for Over Six Years https://biotechmorning.com/news/kalshi-biopharma-prediction-markets-fda Biotech Morning en 2026-07-17T14:21:57.680Z You Can Now Bet Real Money on Whether the FDA Will Approve a Drug https://biotechmorning.com/news/doudna-ai-designed-crispr-enzymes Biotech Morning en 2026-07-17T14:21:01.236Z Jennifer Doudna Just Built CRISPR Enzymes That Evolution Never Imagined https://biotechmorning.com/news/fda-warning-letters-telehealth-compounded-glp1 Biotech Morning en 2026-07-17T14:20:00.917Z The FDA Just Carpet-Bombed 25 Telehealth Companies Over Knockoff Ozempic